Shizuyo Tsujimura

1.3k total citations
33 papers, 969 citations indexed

About

Shizuyo Tsujimura is a scholar working on Rheumatology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shizuyo Tsujimura has authored 33 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 15 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shizuyo Tsujimura's work include Systemic Lupus Erythematosus Research (15 papers), Drug Transport and Resistance Mechanisms (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Shizuyo Tsujimura is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Drug Transport and Resistance Mechanisms (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Shizuyo Tsujimura collaborates with scholars based in Japan, India and Germany. Shizuyo Tsujimura's co-authors include Yoshiya Tanaka, Kazuyoshi Saito, Shingo Nakayamada, Masao Nawata, S. Iwata, Masaki Tokunaga, Kazuhisa Nakano, Y. Imura, Daisuke Kawabata and Takayuki Fujii and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Shizuyo Tsujimura

33 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shizuyo Tsujimura Japan 16 539 286 234 224 136 33 969
Hiroko Kanda Japan 18 273 0.5× 300 1.0× 95 0.4× 55 0.2× 47 0.3× 55 823
Jennifer Visich United States 19 91 0.2× 277 1.0× 192 0.8× 458 2.0× 112 0.8× 34 1.1k
Andrea Fava United States 13 537 1.0× 459 1.6× 147 0.6× 114 0.5× 48 0.4× 32 1.1k
Fu-lin Tang China 15 423 0.8× 385 1.3× 97 0.4× 89 0.4× 38 0.3× 52 860
JT Merrill United States 9 494 0.9× 383 1.3× 66 0.3× 191 0.9× 26 0.2× 26 664
G Sturfelt Sweden 12 760 1.4× 574 2.0× 47 0.2× 141 0.6× 71 0.5× 21 1.1k
Glenn R. Ehresmann United States 10 270 0.5× 253 0.9× 78 0.3× 105 0.5× 103 0.8× 13 739
Luis Caminal‐Montero Spain 15 450 0.8× 353 1.2× 70 0.3× 107 0.5× 43 0.3× 68 762
R Fleischmann United States 8 375 0.7× 213 0.7× 54 0.2× 74 0.3× 79 0.6× 29 674
Norifumi Sawamukai Japan 14 359 0.7× 267 0.9× 72 0.3× 65 0.3× 97 0.7× 25 672

Countries citing papers authored by Shizuyo Tsujimura

Since Specialization
Citations

This map shows the geographic impact of Shizuyo Tsujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizuyo Tsujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizuyo Tsujimura more than expected).

Fields of papers citing papers by Shizuyo Tsujimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizuyo Tsujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizuyo Tsujimura. The network helps show where Shizuyo Tsujimura may publish in the future.

Co-authorship network of co-authors of Shizuyo Tsujimura

This figure shows the co-authorship network connecting the top 25 collaborators of Shizuyo Tsujimura. A scholar is included among the top collaborators of Shizuyo Tsujimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizuyo Tsujimura. Shizuyo Tsujimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsujimura, Shizuyo & Yoshiya Tanaka. (2020). Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartments. Immunological Medicine. 44(3). 142–151. 3 indexed citations
2.
3.
Tsujimura, Shizuyo. (2015). Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis. PubMed. 5(4). 225–225. 22 indexed citations
4.
Tsujimura, Shizuyo & Yoshiya Tanaka. (2011). Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease. Clinical and Experimental Nephrology. 16(1). 102–108. 22 indexed citations
5.
Suzuki, Katsunori, Kazuyoshi Saito, Shizuyo Tsujimura, et al.. (2010). Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis. The Journal of Rheumatology. 37(3). 512–520. 50 indexed citations
6.
Iwata, S., Kazuyoshi Saito, Kunihiro Yamaoka, et al.. (2010). Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease. Modern Rheumatology. 21(2). 184–191. 62 indexed citations
7.
Tsujimura, Shizuyo, Kazuyoshi Saito, Shingo Nakayamada, & Yoshiya Tanaka. (2009). Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis. Modern Rheumatology. 20(2). 139–146. 16 indexed citations
8.
Tsujimura, Shizuyo, Kazuyoshi Saito, Shingo Nakayamada, & Yoshiya Tanaka. (2008). Bolus infusion of human urinary trypsin inhibitor improves intractable interstitial pneumonia in patients with connective tissue diseases. Lara D. Veeken. 47(6). 907–913. 6 indexed citations
9.
Tsujimura, Shizuyo, Kazuyuki Saito, Shingo Nakayamada, & Yoshiya Tanaka. (2007). Relevance of multidrug resistance 1 and P-glycoprotein to drug resistance in patients with systemic lupus erythematosus.. PubMed. 22(4). 465–8. 16 indexed citations
10.
Tsujimura, Shizuyo, Kazuyuki Saito, Masao Nawata, Shingo Nakayamada, & Yoshiya Tanaka. (2007). Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(3). 380–388. 81 indexed citations
11.
Tsujimura, Shizuyo, Kazuyoshi Saito, Kimitoshi Kohno, & Yoshiya Tanaka. (2006). Fragmented Hyaluronan Induces Transcriptional Up-regulation of the Multidrug Resistance-1 Gene in CD4+ T Cells. Journal of Biological Chemistry. 281(49). 38089–38097. 19 indexed citations
12.
Tokunaga, Masaki, Kazuyoshi Saito, Daisuke Kawabata, et al.. (2006). Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Annals of the Rheumatic Diseases. 66(4). 470–475. 256 indexed citations
13.
Tsujimura, Shizuyo, Kazuyoshi Saito, Shingo Nakayamada, & Yoshiya Tanaka. (2005). Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease. Modern Rheumatology. 15(5). 374–380. 5 indexed citations
14.
Tsujimura, Shizuyo, Kazuyoshi Saito, Shingo Nakayamada, Kazuhisa Nakano, & Yoshiya Tanaka. (2005). Clinical relevance of the expression of P‐glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 52(6). 1676–1683. 71 indexed citations
15.
Saito, Kazuyoshi, Shingo Nakayamada, Kazuhisa Nakano, et al.. (2004). Successful treatment of intravenous cyclophosphamide pulse therapy for lupus myelitis with urinary disturbance and acute confusional state. Japanese Journal of Clinical Immunology. 27(5). 338–344. 2 indexed citations
16.
Tsujimura, Shizuyo, Kazuyoshi Saito, Shingo Nakayamada, et al.. (2004). Transcriptional regulation of multidrug resistance‐1 gene by interleukin‐2 in lymphocytes. Genes to Cells. 9(12). 1265–1273. 54 indexed citations
17.
Tokunaga, Masaki, Koichi Fujii, Kazuyoshi Saito, et al.. (2004). Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab. Lara D. Veeken. 44(2). 176–182. 130 indexed citations
18.
Saito, Kazuyoshi, Kazuhisa Nakano, Norifumi Sawamukai, et al.. (2003). Efficacy of mizoribine treatment in patients with Sj�gren?s syndrome: an open pilot trial. Modern Rheumatology. 13(4). 339–345. 1 indexed citations
19.
Nakayamada, Shingo, Kazuyoshi Saito, Kazuhisa Nakano, et al.. (2003). Efficacy of mizoribine treatment in patients with Sjögren’s syndrome: an open pilot trial. Modern Rheumatology. 13(4). 339–345. 11 indexed citations
20.
Saito, Kazuyoshi, Shingo Nakayamada, Kazuhisa Nakano, et al.. (2003). Successful treatment of intravenous cyclophosphamide pulse therapy for systemic lupus erythematosus complicated with steroid-resistant hemolytic anemia. Japanese Journal of Clinical Immunology. 26(5). 304–309. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Kanda Breakdown of academic impact, for papers by Jennifer Visich Breakdown of academic impact, for papers by Andrea Fava Breakdown of academic impact, for papers by Fu-lin Tang Breakdown of academic impact, for papers by JT Merrill Breakdown of academic impact, for papers by G Sturfelt Breakdown of academic impact, for papers by Glenn R. Ehresmann Breakdown of academic impact, for papers by Luis Caminal‐Montero Breakdown of academic impact, for papers by R Fleischmann Breakdown of academic impact, for papers by Norifumi Sawamukai
Rankless by CCL
2026